The calf model of immunity for development of a vaccine against tuberculosis

Janice Endsley, W. Ray Waters, Mitchell V. Palmer, Brian J. Nonnecke, Tyler C. Thacker, William R. Jacobs, Michelle H. Larsen, Alison Hogg, Elisabeth Shell, Martin McAlauy, Charles F Capinosh Scherer, Tracey Coffey, Chris J. Howard, Bernardo Villareal-Ramos, D. Mark Estes

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Tuberculosis (TB) remains a major threat to public health. The identification of safe TB vaccine candidates beyond Mycobacterium bovis BCG, is an exciting prospect for control of human TB and necessary in the context of the human immunodeficiency virus (HIV) pandemic. Selection of vaccine candidates for human trials which are ultimately targeted for use in children less than 5 years of age or in newborns will require an animal model that closely approximates immune function and disease. We propose that the bovine neonate and adolescent is a robust animal model for preclinical safety and efficacy evaluation of TB candidate vaccines targeting this special human population. Parallel studies conducted in bovine neonates and non-human primates with a leading auxotrophic mutant with demonstrated efficacy/safety in a rodent TB model of TB demonstrated similar findings with respect to gross pathology scoring relative to BCG. The findings indicated more numerous and severe lesions in the lung in addition to higher levels of IFN-gamma producing cells. BCG vaccinates demonstrated higher levels of FoxP3 transcripts and lower levels of IL-4 mRNA.

Original languageEnglish (US)
Pages (from-to)199-204
Number of pages6
JournalVeterinary Immunology and Immunopathology
Volume128
Issue number1-3
DOIs
StatePublished - Mar 15 2009

Fingerprint

Tuberculosis Vaccines
vaccine development
Mycobacterium bovis
tuberculosis
Immunity
Tuberculosis
immunity
calves
Newborn Infant
neonates
Animal Models
vaccines
Safety
Immune System Diseases
Pandemics
animal models
Interleukin-4
Primates
Mycobacterium bovis BCG
auxotrophs

Keywords

  • markers
  • neonatal calf
  • prognostic
  • Tuberculosis

ASJC Scopus subject areas

  • Immunology
  • veterinary(all)

Cite this

Endsley, J., Waters, W. R., Palmer, M. V., Nonnecke, B. J., Thacker, T. C., Jacobs, W. R., ... Estes, D. M. (2009). The calf model of immunity for development of a vaccine against tuberculosis. Veterinary Immunology and Immunopathology, 128(1-3), 199-204. https://doi.org/10.1016/j.vetimm.2008.10.312

The calf model of immunity for development of a vaccine against tuberculosis. / Endsley, Janice; Waters, W. Ray; Palmer, Mitchell V.; Nonnecke, Brian J.; Thacker, Tyler C.; Jacobs, William R.; Larsen, Michelle H.; Hogg, Alison; Shell, Elisabeth; McAlauy, Martin; Scherer, Charles F Capinosh; Coffey, Tracey; Howard, Chris J.; Villareal-Ramos, Bernardo; Estes, D. Mark.

In: Veterinary Immunology and Immunopathology, Vol. 128, No. 1-3, 15.03.2009, p. 199-204.

Research output: Contribution to journalArticle

Endsley, J, Waters, WR, Palmer, MV, Nonnecke, BJ, Thacker, TC, Jacobs, WR, Larsen, MH, Hogg, A, Shell, E, McAlauy, M, Scherer, CFC, Coffey, T, Howard, CJ, Villareal-Ramos, B & Estes, DM 2009, 'The calf model of immunity for development of a vaccine against tuberculosis', Veterinary Immunology and Immunopathology, vol. 128, no. 1-3, pp. 199-204. https://doi.org/10.1016/j.vetimm.2008.10.312
Endsley, Janice ; Waters, W. Ray ; Palmer, Mitchell V. ; Nonnecke, Brian J. ; Thacker, Tyler C. ; Jacobs, William R. ; Larsen, Michelle H. ; Hogg, Alison ; Shell, Elisabeth ; McAlauy, Martin ; Scherer, Charles F Capinosh ; Coffey, Tracey ; Howard, Chris J. ; Villareal-Ramos, Bernardo ; Estes, D. Mark. / The calf model of immunity for development of a vaccine against tuberculosis. In: Veterinary Immunology and Immunopathology. 2009 ; Vol. 128, No. 1-3. pp. 199-204.
@article{c31ed456928c4aba92663e0ed9ada008,
title = "The calf model of immunity for development of a vaccine against tuberculosis",
abstract = "Tuberculosis (TB) remains a major threat to public health. The identification of safe TB vaccine candidates beyond Mycobacterium bovis BCG, is an exciting prospect for control of human TB and necessary in the context of the human immunodeficiency virus (HIV) pandemic. Selection of vaccine candidates for human trials which are ultimately targeted for use in children less than 5 years of age or in newborns will require an animal model that closely approximates immune function and disease. We propose that the bovine neonate and adolescent is a robust animal model for preclinical safety and efficacy evaluation of TB candidate vaccines targeting this special human population. Parallel studies conducted in bovine neonates and non-human primates with a leading auxotrophic mutant with demonstrated efficacy/safety in a rodent TB model of TB demonstrated similar findings with respect to gross pathology scoring relative to BCG. The findings indicated more numerous and severe lesions in the lung in addition to higher levels of IFN-gamma producing cells. BCG vaccinates demonstrated higher levels of FoxP3 transcripts and lower levels of IL-4 mRNA.",
keywords = "markers, neonatal calf, prognostic, Tuberculosis",
author = "Janice Endsley and Waters, {W. Ray} and Palmer, {Mitchell V.} and Nonnecke, {Brian J.} and Thacker, {Tyler C.} and Jacobs, {William R.} and Larsen, {Michelle H.} and Alison Hogg and Elisabeth Shell and Martin McAlauy and Scherer, {Charles F Capinosh} and Tracey Coffey and Howard, {Chris J.} and Bernardo Villareal-Ramos and Estes, {D. Mark}",
year = "2009",
month = "3",
day = "15",
doi = "10.1016/j.vetimm.2008.10.312",
language = "English (US)",
volume = "128",
pages = "199--204",
journal = "Veterinary Immunology and Immunopathology",
issn = "0165-2427",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - The calf model of immunity for development of a vaccine against tuberculosis

AU - Endsley, Janice

AU - Waters, W. Ray

AU - Palmer, Mitchell V.

AU - Nonnecke, Brian J.

AU - Thacker, Tyler C.

AU - Jacobs, William R.

AU - Larsen, Michelle H.

AU - Hogg, Alison

AU - Shell, Elisabeth

AU - McAlauy, Martin

AU - Scherer, Charles F Capinosh

AU - Coffey, Tracey

AU - Howard, Chris J.

AU - Villareal-Ramos, Bernardo

AU - Estes, D. Mark

PY - 2009/3/15

Y1 - 2009/3/15

N2 - Tuberculosis (TB) remains a major threat to public health. The identification of safe TB vaccine candidates beyond Mycobacterium bovis BCG, is an exciting prospect for control of human TB and necessary in the context of the human immunodeficiency virus (HIV) pandemic. Selection of vaccine candidates for human trials which are ultimately targeted for use in children less than 5 years of age or in newborns will require an animal model that closely approximates immune function and disease. We propose that the bovine neonate and adolescent is a robust animal model for preclinical safety and efficacy evaluation of TB candidate vaccines targeting this special human population. Parallel studies conducted in bovine neonates and non-human primates with a leading auxotrophic mutant with demonstrated efficacy/safety in a rodent TB model of TB demonstrated similar findings with respect to gross pathology scoring relative to BCG. The findings indicated more numerous and severe lesions in the lung in addition to higher levels of IFN-gamma producing cells. BCG vaccinates demonstrated higher levels of FoxP3 transcripts and lower levels of IL-4 mRNA.

AB - Tuberculosis (TB) remains a major threat to public health. The identification of safe TB vaccine candidates beyond Mycobacterium bovis BCG, is an exciting prospect for control of human TB and necessary in the context of the human immunodeficiency virus (HIV) pandemic. Selection of vaccine candidates for human trials which are ultimately targeted for use in children less than 5 years of age or in newborns will require an animal model that closely approximates immune function and disease. We propose that the bovine neonate and adolescent is a robust animal model for preclinical safety and efficacy evaluation of TB candidate vaccines targeting this special human population. Parallel studies conducted in bovine neonates and non-human primates with a leading auxotrophic mutant with demonstrated efficacy/safety in a rodent TB model of TB demonstrated similar findings with respect to gross pathology scoring relative to BCG. The findings indicated more numerous and severe lesions in the lung in addition to higher levels of IFN-gamma producing cells. BCG vaccinates demonstrated higher levels of FoxP3 transcripts and lower levels of IL-4 mRNA.

KW - markers

KW - neonatal calf

KW - prognostic

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=60549111022&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60549111022&partnerID=8YFLogxK

U2 - 10.1016/j.vetimm.2008.10.312

DO - 10.1016/j.vetimm.2008.10.312

M3 - Article

VL - 128

SP - 199

EP - 204

JO - Veterinary Immunology and Immunopathology

JF - Veterinary Immunology and Immunopathology

SN - 0165-2427

IS - 1-3

ER -